@article {240,
	title = {The Biomedical Engineer{\textquoteright}s Pledge: Overview and Context},
	journal = {Medical \& Biological Engineering \& Computing},
	volume = {(Published online)},
	year = {2025},
	doi = {10.1007/s11517-025-03443-6},
	url = {https://doi.org/10.1007/s11517-025-03443-6},
	author = {Antoni Ivorra and Txetxu Aus{\'\i}n and Laura Becerra-Fajardo and del Ama, Antonio J. and Jesus Minguillon and Aracelys Garc{\'\i}a-Moreno and Jordi Aguil{\'o} and Filipe O. Barroso and Bijnens, Bart and Oscar Camara and Sara Capdevila and Castellanos-Fernandez, Roger and Rafael Davalos and Jean-Louis Divoux and Ahmed Eladly and Dario Farina and Garc{\'\i}a-Hombravella, Carla and Gonz{\'a}lez-L{\'o}pez, Raquel and C{\'e}sar Gonz{\'a}lez and Jordi Gr{\'\i}fols and Felipe Maglietti and Shahid Malik and Elad Maor and Guillermo Marshall and Mateu-Yus, Berta and Lluis M. Mir and Moreno, Juan C. and Xavier Navarro and N{\'u}ria Noguera and Andr{\'e}s Ozaita and Gemma Piella and Pons, Jos{\'e} Luis and Rita Quesada and Pilar Rivera-Gil and Boris Rubinsky and Ruiz-Garcia, Aurelio and Ruiz-Vargas, Albert and S{\'a}nchez-S{\'a}nchez, Maria and Andreas Schneider and Ting Shu and Villa-Sanz, Rosa and Bing Zhang and Gema Revuelta}
}
@article {169,
	title = {Avoiding neuromuscular stimulation in liver irreversible electroporation using radiofrequency electric fields},
	journal = {Physics in Medicine and Biology},
	volume = {63},
	year = {2018},
	pages = {035027},
	chapter = {035027},
	doi = {10.1088/1361-6560/aaa16f},
	author = {Q. Castellv{\'\i} and Borja Mercadal and Xavier Moll and Fontdevila, Dolors and Andaluz, Anna and Antoni Ivorra}
}
@article {Jose2012,
	title = {{Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models.}},
	journal = {Cancer letters},
	volume = {317},
	number = {1},
	year = {2012},
	pages = {16{\textendash}23},
	abstract = {<p>Pancreatic ductal adenocarcinoma (PDAC) therapies show limited success. Irreversible electroporation (IRE) is an innovative loco-regional therapy in which high-voltage pulses are applied to induce plasma membrane defects leading to cellular death. In the present study we evaluated the feasibility of IRE against PDAC. IRE treatment exhibited significant antitumor effects and prolonged survival in mice with orthotopic xenografts. Extensive tumor necrosis, reduced tumor cell proliferation and disruption of microvessels were observed at different days post-IRE. Animals had transient increases in transaminases, amylase and lipase enzymes that normalized at 24h post-IRE. These results suggest that IRE could be an effective treatment for locally advanced pancreatic tumors.</p>
},
	keywords = {Alanine Transaminase, Alanine Transaminase: blood, Amylases, Amylases: blood, Animals, Aspartate Aminotransferases, Aspartate Aminotransferases: blood, Biological Markers, Biological Markers: blood, Blood Glucose, Blood Glucose: metabolism, Carcinoma, Cell Line, Cell Proliferation, Electrochemotherapy, Electrochemotherapy: adverse effects, Feasibility Studies, Genes, Humans, Lipase, Lipase: blood, Luminescent Measurements, Male, Mice, Microvessels, Microvessels: pathology, Necrosis, Nude, Pancreatic Ductal, Pancreatic Ductal: blood, Pancreatic Ductal: blood supply, Pancreatic Ductal: genetics, Pancreatic Ductal: pathology, Pancreatic Ductal: therapy, Pancreatic Neoplasms, Pancreatic Neoplasms: blood, Pancreatic Neoplasms: blood supply, Pancreatic Neoplasms: genetics, Pancreatic Neoplasms: pathology, Pancreatic Neoplasms: therapy, Reporter, Time Factors, Transfection, Tumor, Xenograft Model Antitumor Assays},
	issn = {1872-7980},
	doi = {10.1016/j.canlet.2011.11.004},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/22079741},
	author = {Jos{\'e}, Anabel and Sobrevals, Luciano and Antoni Ivorra and Fillat, Cristina}
}
